Cocrystal Screening of Stanolone and Mestanolone Using Slurry Crystallization
Source abstract
Abstract
A slurry crystallization technique was used in cocrystal screening of two nonionizable pharmaceutical host compounds, stanolone and mestanolone, with 11 pharmaceutically acceptable guest acids. Crystallization was performed simply by adding crystallization solvents to solid mixtures of a host and a guest, which had been prepared using lyophilization of their dimethyl sulfoxide solution. Powder X-ray diffraction and thermogravimetric/differential thermal analysis were used to identify new solid forms. Two resultant new forms, stanolone l -tartaric acid 1:1 cocrystal and mestanolone salicylic acid 1:1 cocrystal, were characterized using single-crystal X-ray diffraction. The hosts, despite having the same steroidal skeleton and the same functional groups that form strong hydrogen bonds, each formed a cocrystal with a different guest molecule. All functional groups of the host and guest molecules that form strong hydrogen bonds were engaged in hydrogen bonding, but, despite the highly analogous molecular structures of the hosts, the two cocrystals exhibited dissimilar crystal structures. The present study shows the slurry technique to be viable and practical for cocrystal screening and demonstrates the importance not only of hydrogen bonding but also of geometric fit in cocrystal formation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · Crystal structures of chemical compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan, and Faculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8501, Japan
References (30)
Show source-provided references
1. Stahly G. P. · Cryst. Growth Des. · 2007 · 7 · 100710.1021/cg060838j ↗
2. Byrn S. R. · 1999
3. Huang L-F. · Adv. Drug Delivery Rev. · 2004 · 56 · 32110.1016/j.addr.2003.10.007 ↗
4. Remenar J. F. · J. Am. Chem. Soc. · 2003 · 125 · 845610.1021/ja035776p ↗
5. Childs S. L. · J. Am. Chem. Soc. · 2004 · 126 · 1333510.1021/ja048114o ↗
6. Variankaval N. · Cryst. Growth Des. · 2006 · 6 · 69010.1021/cg050462u ↗
7. McNamara D. P. · Pharm. Res. · 2006 · 23 · 188810.1007/s11095-006-9032-3 ↗
8. Remenar J. F. · Mol. Pharmaceutics · 2007 · 4 · 38610.1021/mp0700108 ↗
9. Trask A. V. · Cryst. Growth Des. · 2005 · 5 · 101310.1021/cg0496540 ↗
10. Trask A. V. · Int. J. Pharm. · 2006 · 320 · 11410.1016/j.ijpharm.2006.04.018 ↗
11. Stahl P. H. · 2002
12. Paulekuhn G. S. · J. Med. Chem. · 2007 · 50 · 666510.1021/jm701032y ↗
13. Trask A. V. · Chem. Commun. · 2004 · 89010.1039/b400978a ↗
14. Trask A. V. · Cryst. Growth Des. · 2005 · 5 · 223310.1021/cg0501682 ↗
15. Karki S. · Mol. Pharmaceutics · 2007 · 4 · 34710.1021/mp0700054 ↗
16. Childs S. L. · Cryst. Growth Des. · 2007 · 7 · 129110.1021/cg060742p ↗
17. Nehm S. J. · Cryst. Growth Des. · 2006 · 6 · 59210.1021/cg0503346 ↗
18. Rodríguez-Hornedo N. · Mol. Pharmaceutics · 2006 · 3 · 36210.1021/mp050099m ↗
19. Zhang G. G. Z. · J. Pharm. Sci. · 2007 · 96 · 99010.1002/jps.20949 ↗
20. Gu C-H. · J. Pharm. Sci. · 2001 · 90 · 187810.1002/jps.1137 ↗
21. Miller J. M. · Pharm. Dev. Technol. · 2005 · 10 · 291
22. He X. · J. Pharm. Sci. · 2001 · 90 · 37110.1002/1520-6017(200103)90:3<371::AID-JPS12>3.0.CO;2-N ↗
23. Sun C. · Int. J. Pharm. · 2006 · 319 · 11410.1016/j.ijpharm.2006.03.044 ↗
24. Altomare A. · J. Appl. Crystallogr. · 1994 · 27 · 435
25. Courseille C. · Cryst. Struct. Commun. · 1973 · 2 · 441
26. Busetta B. · Cryst. Struct. Commun. · 1972 · 1 · 43
27. Etter M. C. · Acc. Chem. Res. · 1990 · 23 · 12010.1021/ar00172a005 ↗
28. Etter M. C. · J. Phys. Chem. · 1991 · 95 · 460110.1021/j100165a007 ↗
29. Fleischman S. C. · Cryst. Growth Des. · 2003 · 3 · 90910.1021/cg034035x ↗
30. Ruzicka L. · Helv. Chim. Acta · 1935 · 18 · 148710.1002/hlca.193501801203 ↗